Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App

Long-acting HIV prevention jab records no major health concerns

Lenacapavir rollout in Kenya shows minimal side effects, with only mild injection pain reported. [File Courtesy]

No major adverse effects have been reported since the rollout of the long-acting HIV prevention injection, Lenacapavir, a month ago.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902